Overview of Prudentia data sources

Prudentia draws on two distinct categories of data to power its modules: platform data sources that Prudentia continuously maintains and curates, and customer data that your organization brings into the platform. The balance between these depends on where you are in the evaluation process: early-stage sourcing and screening relies primarily on Prudentia's proprietary and public data, while deeper diligence incorporate confidential data from your organization or the partner you are evaluating.

Overview of Prudentia data sources

Prudentia's modules are powered by a continuously updated, curated data sources spanning clinical, regulatory, scientific, and commercial domains. These include:

Proprietary global asset data. Prudentia's propietary, curated database of approved and pre-approved drug assets across geographies, with particular geographic depth in US, EU, UK, and China.
Clinical trial databases. Structured data on ongoing and completed trials, including endpoints, enrollment, phase, sponsor, and results where available.
Regulatory filings and approvals. FDA, EMA, NMPA, and other major regulatory agency records, including approval history, label data, and advisory committee outcomes.
Scientific literature. Published clinical and preclinical research indexed and synthesized to support Prism evaluation outputs.
Patent databases. Connections to patent sources such as USPTO to surface patent landscape, assess IP strength, and assess freedom-to-operate considerations
News and deal intelligence. Connections to news sources and deal databases that track recent transaction activity, including licensing deals, acquisitions, and financing events

Customer data

As an asset moves beyond initial screening and into evaluation, Prudentia can incorporate your organization's proprietary or your deal partner's confidential data to enrich analyses, contextualize findings within the specifics of your deal or program, and drive end to end due diligence.

Customer data enters Prudentia in three ways:

Direct upload. Documents can be uploaded directly to any Evaluation. Supported file types include PDF, Word (.docx), PowerPoint (.pptx), and Excel (.xlsx). Uploaded materials, such as a confidential data package or clinical study report, are processed and synthesized in the Evaluation output.
Virtual Data Room (VDR) integrations. Prudentia connects natively to Box and Ansarada, allowing you to link a VDR folder or data room to a Project without manual file transfers. See the Data Integrations section of this Knowledge Base for setup instructions.
Manual input. When configuring a Prism evaluation, you provide key parameters - such as indication, development stage, mechanism of action - that shape how Prudentia runs its LLM-powered analyses

Data privacy and isolation

All customer data in Prudentia is fully isolated to your organization's workspace. Platform data sources are shared infrastructure, but your Evaluation - including uploaded documents, VDR-linked files, and analyses - are never accessible to other organizations on the platform. Customer data is subject to Prudentia's data retention and deletion policies.